跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SETRELVO ustekinumab 45 mg/ 0.5 mL solution for injection pre-filled pen (One-Press patient-controlled injector) - TGA Drug Approval Details
Approvals
/
TGA
/
SETRELVO ustekinumab 45 mg/ 0.5 mL solution for injection pre-filled pen (One-Press patient-controlled injector)
Approved
STANDARD
SETRELVO ustekinumab 45 mg/ 0.5 mL solution for injection pre-filled pen (One-Press patient-controlled injector)
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2c1586be986e4500
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
2c1586be986e4500
Product Name
SETRELVO ustekinumab 45 mg/ 0.5 mL solution for injection pre-filled pen (One-Press patient-controlled injector)
Artg Id
462457
Artg Name
SETRELVO ustekinumab 45 mg/ 0.5 mL solution for injection pre-filled pen (One-Press patient-controlled injector)
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
2024-10-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2c1586be986e4500
Type
Standard
Back to TGA Approvals